Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

How I treat cold agglutinin disease

Sigbjørn Berentsen

Blood (2021) 137 (10): 1295–1303.

https://doi.org/10.1182/blood.2019003809

Published: 2021

Journal Articles

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Blood (2020) 136 (4): 480–488.

https://doi.org/10.1182/blood.2020005674

Published: 2020

Includes: Supplemental data

Journal Articles

Do temperature and time matter in cold agglutinin disease?

Alexander Röth

Blood (2020) 136 (4): 380–381.

https://doi.org/10.1182/blood.2020006566

Published: 2020

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Sarah A Lau-Braunhut, MD, Hannah Stone, Griffin Collins, MD, Sigbjørn Berentsen, MD PhD, Matt Zinter, MD, Benjamin Braun, MD PhD

Blood (2019) 134 (Supplement_1): 4798.

https://doi.org/10.1182/blood-2019-126365

Published: 2019

Journal Articles

Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease

Surbhi Sidana, MD, David L Murray, MD PhD, Surendra Dasari, PhD, Ronald S. Go, MD, Maria Alice Willrich, PhD, Melissa Snyder, PhD, Mindy Kohlhagen, John A. Lust, MD PhD, Eli Muchtar, MD, Taxiarchis Kourelis, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD

Blood (2019) 134 (Supplement_1): 3510.

https://doi.org/10.1182/blood-2019-121712

Published: 2019

Journal Articles

Cold Agglutinin Disease Transfusion Practices in the United States: An Electronic Medical Record-Based Analysis

Jun Su, Rajeshwari Punekar, Jaime Morales Arias, Nisha Jain

Blood (2019) 134 (Supplement_1): 3690.

https://doi.org/10.1182/blood-2019-122209

Published: 2019

Journal Articles

Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia from Busulfan to the Era of Tyrosine Kinase Inhibitors

Mohamed A Yassin, MBBS, MSc, Tahseen Hamamyh, MD

Blood (2019) 134 (Supplement_1): 5917.

https://doi.org/10.1182/blood-2019-121433

Published: 2019

Journal Articles

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Agnieszka Malecka, Jan Delabie, MD PhD, Ingunn Ostlie, Anne Tierens, MD PhD, Ulla Randen, MD PhD, Sigbjorn Berentsen, MD PhD, Geir Erland Tjønnfjord, MD PhD, Gunhild Trøen

Blood (2019) 134 (Supplement_1): 1488.

https://doi.org/10.1182/blood-2019-121750

Published: 2019

Journal Articles

Mortality Among Patients with Cold Agglutinin Disease in the United States: An Electronic Health Record (EHR)-Based Analysis

Quentin A. Hill, Rajeshwari Punekar, Jaime Morales Arias, Catherine M Broome, MD, Jun Su

Blood (2019) 134 (Supplement_1): 4790.

https://doi.org/10.1182/blood-2019-122140

Published: 2019

Journal Articles

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Catherine M Broome, MD, Alexander Röth, MD PhD, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs

Blood (2019) 134 (Supplement_1): 898.

https://doi.org/10.1182/blood-2019-122210

Published: 2019

Journal Articles

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Christian Sillaber, Petra Jilma-Stohlawetz, Michael Fillitz, Thomas Schenk, Gary Patou, Sandip Panicker, Graham C. Parry, James C. Gilbert, Bernd Jilma

Blood (2019) 133 (9): 893–901.

https://doi.org/10.1182/blood-2018-06-856930

Published: 2019

Includes: Supplemental data

Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Federico Grossi, MD, Merrill Kingman Shum, MD, Morie A. Gertz, MD, Eloy Roman, MD, Pascal Deschatelets, PhD, Mohamed Hamdani, MS, Frank Stout, Cedric G Francois, MD PhD

Blood (2018) 132 (Supplement 1): 3623.

https://doi.org/10.1182/blood-2018-99-119468

Published: 2018

Journal Articles

Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition

Ferras Alashkar, MD, Doerte Herich-Terhuerne, Nicole Preising, Ulrich Duehrsen, MD, Vogel Ulrich, MD, Alexander Röth, MD

Blood (2018) 132 (Supplement 1): 3817.

https://doi.org/10.1182/blood-2018-99-118968

Published: 2018

Journal Articles

Prognosis of Patients with Waldenström Macroglobulinemia: A Simplified Model

Saurabh Zanwar, MBBS, Jithma Prasad Abeykoon, MD, Stephen M. Ansell, MD PhD, Angela Dispenzieri, MD, Morie A. Gertz, MD, David J Inwards, MD, Thomas E. Witzig, MD, Martha Q. Lacy, MD, Thomas M. Habermann, MD, David Dingli, MD PhD, Francis K. Buadi, MB, CHB, Ronald S. Go, MD, Wilson I Gonsalves, MD, Eli Muchtar, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, Prashant Kapoor, MD

Blood (2018) 132 (Supplement 1): 4152.

https://doi.org/10.1182/blood-2018-99-119849

Published: 2018

Journal Articles

Seasonal Patterns of Anemia, Hemolytic Markers and Healthcare Resource Utilization Among Patients with Cold Agglutinin Disease in the United States: A Retrospective Analysis

Alexander Röth, MD, Jon Fryzek, Xiaohui Jiang, Jaime Morales, Catherine M. Broome

Blood (2018) 132 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2018-99-116893

Published: 2018

Journal Articles

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study

Giuseppe Rossi, Doriana Gramegna, Francesca Paoloni, Bruno Fattizzo, Francesca Binda, Mariella D’Adda, Mirko Farina, Elisa Lucchini, Francesca Romana Mauro, Flavia Salvi, Monia Marchetti, Paola Fazi, Francesco Zaja, Wilma Barcellini

Blood (2018) 132 (5): 547–550.

https://doi.org/10.1182/blood-2018-03-835413

Published: 2018

Journal Articles

Healthcare Resource Utilization in Autoimmune Hemolytic Anemia Patients: Analysis of 190 Cases from a Single Center

Wilma Barcellini, MD, Bruno Fattizzo, MD, Anna Zaninoni, BS, juri A. Giannotta, Valeria Ferri, Alberto Zanella, MD, Agostino Cortelezzi, Prof

Blood (2017) 130 (Supplement 1): 3370.

https://doi.org/10.1182/blood.V130.Suppl_1.3370.3370

Published: 2017

Journal Articles

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

Yun Liu, MS, Rosa Catera, PhD, Chao Gao, PhD, Xiao J. Yan, MDPhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Kanti Rai, MD, Charles C Chu, PhD, Ten Feizi, MD, Kostas Stamatopoulos, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 58.

https://doi.org/10.1182/blood.V130.Suppl_1.58.58

Published: 2017

Journal Articles

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

Giuseppe Rossi, MD, Francesca Paoloni, Bruno Fattizzo, MD, Francesca Binda, MD, Mariella D'Adda, MD, Mirko Farina, MD, Cecilia Carbone, MD, Francesco Zaja, MD, Elisa Lucchini, MD, Francesca Romana Mauro, MD, Flavia Salvi, MD, Monia Marchetti, MD, Paola Fazi, Wilma Barcellini, MD

Blood (2017) 130 (Supplement 1): 2199.

https://doi.org/10.1182/blood.V130.Suppl_1.2199.2199

Published: 2017

NARROW

How I treat cold agglutinin disease

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Do temperature and time matter in cold agglutinin disease?

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease

Cold Agglutinin Disease Transfusion Practices in the United States: An Electronic Medical Record-Based Analysis

Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia from Busulfan to the Era of Tyrosine Kinase Inhibitors

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Mortality Among Patients with Cold Agglutinin Disease in the United States: An Electronic Health Record (EHR)-Based Analysis

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Serologic Response to Meningococcal Vaccination in Patients with Cold Agglutinin Disease (CAD) in the New Era of Complement Inhibition

Prognosis of Patients with Waldenström Macroglobulinemia: A Simplified Model

Seasonal Patterns of Anemia, Hemolytic Markers and Healthcare Resource Utilization Among Patients with Cold Agglutinin Disease in the United States: A Retrospective Analysis

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study

Healthcare Resource Utilization in Autoimmune Hemolytic Anemia Patients: Analysis of 190 Cases from a Single Center

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only